Inventor
Josef Heindl
Inventor
Berlin, DE
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds31%
C07CAcyclic or carbocyclic compounds26%
C07JSteroids7%
A61KPreparations for medical, dental or toiletry purposes2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
PatentTitleYear
6,271,403'7.alpha.-(xi-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7.alpha.-(xi-aminoalkyl-estratrienes as well as their use for the production of pharmaceutical agents'20015,986,115'7.alpha.-(.xi.-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7.alpha.-(.xi.-aminoalkyl)-estratrienes as well as their use for the production of pharmaceutical agents'19995,866,560'7.alpha.-(.xi.-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7.alpha.-(.xi.-aminoalkyl)-estratrienes as well as their use for the production of pharmaceutical agents'19995,859,054'Leukotriene B4 derivatives, process for their production and their use as pharmaceutical agents'19995,783,602'Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents'19985,624,943'Pyridine compounds which are useful as leukotriene-B.sub.4 -antagonists'19975,614,634'Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents'19975,559,134'Leukotriene-B.sub.4 antagonists, process for their production and their use as pharmaceutical agents'19965,541,202'New leukotriene-B4 Antagonists and their use as pharmaceutical agents'19965,502,075'Leukotriene-B.sub.4 derivatives, process for their production and their use as pharmaceutical agents'19965,440,044'Leukotriene-B.sub.4 derivatives, process for their production and their use as pharmaceutical agents'19955,414,016'New leukotriene-B.sub.4 derivatives, process for their production and their use as pharmaceutical agents'19955,352,701'Leukotriene-B.sub.4 antagonist compounds and their use as pharmaceutical agents'19945,187,286'Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents'19935,183,925'Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents'19935,158,957'2-substituted ergolines'19925,037,832'2-substituted ergolines'19914,863,929'12- and 13-substituted ergoline derivatives having alpha.sub.2 -receptor-blocking effect'19894,835,175'Indole derivatives pharmaceutical preparations based thereon, and .beta.-receptor stimulation therewith'19894,740,509'12- and 13-bromoergolines useful for treating hypertension'1988Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1988–2001Patents assigned to SCHERING AG (20)· patent assignee history
1988–2001Based in Berlin, DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SCHERING AG | 20 | 1988–2001 |
Locations
| Location | Patents | Span |
|---|---|---|
| Berlin, DE | 20 | 1988–2001 |